Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
106.41
+0.93 (0.88%)
At close: Aug 6, 2026, 4:00 PM EDT
108.53
+2.12 (1.99%)
After-hours: Aug 6, 2026, 7:54 PM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $8.85 billion as of August 6, 2026. Its market cap has increased by 193.47% in one year.
Market Cap
8.85B
Enterprise Value
7.42B
1-Year Change
193.47%
Ranking
Category
Stock Price
$106.41
ChartMarket Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $8.85B, an increase of 960.31%. That is a compound annual growth rate of 48.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 8.85B | 42.14% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 10.09B |
| Halozyme Therapeutics | 9.95B |
| Krystal Biotech | 9.74B |
| Spyre Therapeutics | 9.33B |
| Protagonist Therapeutics | 9.26B |
| Ionis Pharmaceuticals | 9.16B |
| Crinetics Pharmaceuticals | 8.91B |
| Vaxcyte | 8.52B |